Vesugen
Vesugen. Three-amino-acid Khavinson bioregulator marketed for blood-vessel health; evidence is limited to small, mostly Russian studies.
How it works. Proposed to regulate gene expression in blood-vessel wall cells. The mechanism is not established.
What the research supports. 1 graded claims. Strongest: Vascular aging markers in cell studies and small trials (preclinical).
Side effects and interactions. 0 medication interactions listed. Serious: Unknown long-term safety.
Common forms. Available as Oral capsules, Injection (research).
Community. Experiences from people who have tried Vesugen. Anecdotes are not medical advice.
Vesugen. Three-amino-acid Khavinson bioregulator marketed for blood-vessel health; evidence is limited to small, mostly Russian studies.
What it is
A synthetic Lys-Glu-Asp tripeptide. Claims about vascular aging come from cell studies and small trials from the same research school.
Also called
How it works
Proposed to regulate gene expression in blood-vessel wall cells. The mechanism is not established.
Pathways
- Endothelial gene expression (proposed)
Effects
- +Vascular cell function (cell studies) supports
What the research supports
Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.
Side effects & interactions
Common side effects
- Few side effects reported; data limited
Serious
- Unknown long-term safety
No notable medication interactions listed.
Check any supplement–medication combination with your pharmacist before starting.
Common forms
- Oral capsules
- Injection (research)
Discussion
Loading discussion…